HuGE Literature Finder
Records 1-4
The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma.
Cancer prevention research (Philadelphia, Pa.) 2012 Jan 5 (1): 61-72. Chan Andrew T, Hsu Meier, Zauber Ann G, Hawk Ernest T, Bertagnolli Monica |
Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Nov 12 (21): 6585-9. Hubner Richard A, Muir Kenneth R, Liu Jo-Fen, Logan Richard F A, Grainge Matthew, Armitage Nicholas, Shepherd Vic, Popat Sanjay, Houlston Richard S, |
Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
Journal of the National Cancer Institute 2005 Mar 97 (6): 457-60. Chan Andrew T, Tranah Gregory J, Giovannucci Edward L, Hunter David J, Fuchs Charles |
CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
Cancer research 2001 May 61 (9): 3566-9. Bigler J, Whitton J, Lampe J W, Fosdick L, Bostick R M, Potter J |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: